 Cardiomyopathies
"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Descriptor ID |
D009202
|
| MeSH Number(s) |
C14.280.238
|
| Concept/Terms |
Cardiomyopathies- Cardiomyopathies
- Cardiomyopathy
- Myocardial Diseases
- Disease, Myocardial
- Diseases, Myocardial
- Myocardial Disease
- Myocardiopathies
- Myocardiopathy
Cardiomyopathies, Secondary- Cardiomyopathies, Secondary
- Cardiomyopathy, Secondary
- Secondary Cardiomyopathies
- Secondary Cardiomyopathy
- Secondary Myocardial Diseases
- Disease, Secondary Myocardial
- Diseases, Secondary Myocardial
- Myocardial Disease, Secondary
- Secondary Myocardial Disease
- Myocardial Diseases, Secondary
Cardiomyopathies, Primary- Cardiomyopathies, Primary
- Cardiomyopathy, Primary
- Primary Cardiomyopathies
- Primary Cardiomyopathy
- Primary Myocardial Diseases
- Myocardial Diseases, Primary
- Disease, Primary Myocardial
- Diseases, Primary Myocardial
- Myocardial Disease, Primary
- Primary Myocardial Disease
|
Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".
Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".
This graph shows the total number of publications written about "Cardiomyopathies" by people in UAMS Profiles by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2024 | 1 | 0 | 1 | | 2023 | 6 | 0 | 6 | | 2022 | 9 | 0 | 9 | | 2021 | 4 | 0 | 4 | | 2020 | 7 | 1 | 8 | | 2019 | 5 | 0 | 5 | | 2018 | 2 | 0 | 2 | | 2017 | 2 | 2 | 4 | | 2016 | 4 | 0 | 4 | | 2015 | 4 | 2 | 6 | | 2014 | 4 | 0 | 4 | | 2013 | 2 | 0 | 2 | | 2012 | 2 | 1 | 3 | | 2011 | 1 | 1 | 2 | | 2010 | 2 | 1 | 3 | | 2009 | 1 | 1 | 2 | | 2008 | 1 | 1 | 2 | | 2007 | 0 | 1 | 1 | | 2006 | 1 | 0 | 1 | | 2005 | 0 | 2 | 2 | | 2004 | 0 | 1 | 1 | | 2003 | 2 | 1 | 3 | | 2002 | 1 | 0 | 1 | | 1999 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 1993 | 1 | 0 | 1 | | 1990 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiomyopathies" by people in Profiles over the past ten years.
-
Malik A, Bagchi AK, Jassal DS, Singal PK. Doxorubicin-induced cardiomyopathy is mitigated by empagliflozin via the modulation of endoplasmic reticulum stress pathways. Mol Med Rep. 2024 May; 29(5).
-
Mosgrove MJ, Sachdeva R, Stratton KL, Armenian SH, Bhat A, Leger KJ, Yang C, Leisenring WM, Meacham LR, Sadak KT, Narasimhan SL, Nathan PC, Chow EJ, Border WL. Utility of apical four-chamber longitudinal strain in the assessment of childhood cancer survivors: A multicenter study. Echocardiography. 2024 Feb; 41(2):e15766.
-
Kamsheh AM, Meyers KE, Palermo RA, Wu L, Burstein DS, Edelson JB, Lin KY, Maeda K, Rossano JW, Wittlieb-Weber CA, O'Connor MJ. Hypertension: An Important But Reversible Cause of Systolic Dysfunction in a Cohort of Pediatric Patients. Pediatr Cardiol. 2024 Feb; 45(2):331-339.
-
von Bardeleben RS, Mahoney P, Morse MA, Price MJ, Denti P, Maisano F, Rogers JH, Rinaldi M, De Marco F, Rollefson W, Chehab B, Williams M, Leurent G, Asch FM, Rodriguez E. 1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study. JACC Cardiovasc Interv. 2023 11 13; 16(21):2600-2610.
-
von Bardeleben RS, Rogers JH, Mahoney P, Price MJ, Denti P, Maisano F, Rinaldi M, Rollefson WA, De Marco F, Chehab B, Williams MR, Asch FM, Rodriguez E. Real-World Outcomes of Fourth-Generation Mitral Transcatheter?Repair: 30-Day Results From EXPAND G4. JACC Cardiovasc Interv. 2023 06 26; 16(12):1463-1473.
-
Rogers JH, Asch F, Sorajja P, Mahoney P, Price MJ, Maisano F, Denti P, Morse MA, Rinaldi M, Bedogni F, De Marco F, Rollefson W, Chehab B, Williams MR, Leurent G, Morikawa T, Asgar AW, Rodriguez E, von Bardeleben RS, Kar S. Expanding the Spectrum of TEER?Suitability: Evidence From the EXPAND G4 Post Approval Study. JACC Cardiovasc Interv. 2023 06 26; 16(12):1474-1485.
-
Shantha G, Singleton M, Kozak P, Bodziock G, Atreya AR, Narasimhan B, Deshmukh A, Liang JJ, Hranitzky P, Whalen P, Bhave P. Role of dofetilide in patients with ventricular arrhythmias. J Interv Card Electrophysiol. 2024 Jan; 67(1):91-97.
-
Al'Aref SJ, Altibi AM, Malkawi A, Mansour M, Baskaran L, Masri A, Rahmouni H, Abete R, Andreini D, Aquaro G, Barison A, Bogaert J, Camastra G, Carigi S, Carrabba N, Casavecchia G, Censi S, Cicala G, Conte E, De Cecco CN, De Lazzari M, Di Giovine G, Di Roma M, Dobrovie M, Focardi M, Gaibazzi N, Gismondi A, Gravina M, Guglielmo M, Lanzillo C, Lombardi M, Lorenzoni V, Lozano-Torres J, Margonato D, Martini C, Marzo F, Masci P, Masi A, Memeo R, Moro C, Mushtaq S, Nese A, Palumbo A, Pavon AG, Pedrotti P, Pepi M, Perazzolo Marra M, Pica S, Pradella S, Presicci C, Rabbat MG, Raineri C, Rodriguez-Palomares JF, Sbarbati S, Schoepf UJ, Squeri A, Sverzellati N, Symons R, Tat E, Timpani M, Todiere G, Valentini A, Varga-Szemes A, Volpe A, Fusini L, Guaricci AI, Schwitter J, Pontone G. Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy. Eur Heart J Cardiovasc Imaging. 2023 03 21; 24(4):472-482.
-
Abdelrahim E, Birchak J, Khan A, Maskoun W. Iatrogenic cardiomyopathy in patients with manifest right supero-paraseptal accessory pathways. Pacing Clin Electrophysiol. 2023 11; 46(11):1370-1374.
-
Kumar A, Ravi R, Sivakumar RK, Chidambaram V, Majella MG, Sinha S, Adamo L, Lau ES, Al'Aref SJ, Asnani A, Sharma G, Mehta JL. Prolactin Inhibition in Peripartum Cardiomyopathy: Systematic Review and Meta-analysis. Curr Probl Cardiol. 2023 Feb; 48(2):101461.
-
Williams M, Capcha JMC, Irion CI, Seo G, Lambert G, Kamiar A, Yousefi K, Kanashiro-Takeuchi R, Takeuchi L, Saad AG, Mendez A, Webster KA, Goldberger JJ, Hare JM, Shehadeh LA. Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low-Density Lipoprotein Receptor Expression. J Am Heart Assoc. 2022 09 06; 11(17):e027216.
-
Peterson TE, Landon C, Haberlen SA, Bhondoekhan F, Plankey MW, Palella FJ, Piggott DA, Margolick JB, Brown TT, Post WS, Wu KC. Circulating biomarker correlates of left atrial size and myocardial extracellular volume fraction among persons living with and without HIV. BMC Cardiovasc Disord. 2022 09 03; 22(1):393.
-
Connor BS, Algaze CA, Narkeviciute A, Anguiano B, Pariani M, Zarate YA, Collins RT. Prevalence and Outcomes of Primary Left Ventricular Dysfunction in Marfan Syndrome. Am J Cardiol. 2022 07 15; 175:119-126.
-
Abbas J, Zulqarnain M, Waqar F, Waqar Z, Malik J, Satti DI, Zaidi SMJ. Incidence and predictors of pacemaker-induced cardiomyopathy with right ventricular pacing: a systematic review. Expert Rev Cardiovasc Ther. 2022 Apr; 20(4):267-273.
-
Amer F, Alzghoul BN, Jaber JF, Ali A, Kalra SS, Innabi A, Alzghoul B, Ghaith S, Al-Hakim T, Gomez DM, Barb D, Woodmansee WW, Patel DC. Prevalence and Characteristics of Hyperthyroidism Among Patients With Sarcoidosis in the United States. Endocr Pract. 2022 Jul; 28(7):654-659.
-
Mathai SV, Patel S, Jorde UP, Rochlani Y. Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis. Methodist Debakey Cardiovasc J. 2022; 18(2):78-93.
-
Kim C, Park CH, Kim DY, Cha J, Lee BY, Park CH, Kang EJ, Koo HJ, Kitagawa K, Cha MJ, Krittayaphong R, Choi SI, Viswamitra S, Ko SM, Kim SM, Hwang SH, Trang NN, Lee W, Kim YJ, Lee J, Yang DH. Semi-Quantitative Scoring of Late Gadolinium Enhancement of the Left Ventricle in Patients with Ischemic Cardiomyopathy: Improving Interobserver Reliability and Agreement Using Consensus Guidance from the Asian Society of Cardiovascular Imaging-Practical Tutorial (ASCI-PT) 2020. Korean J Radiol. 2022 03; 23(3):298-307.
-
Villa C, Auerbach SR, Bansal N, Birnbaum BF, Conway J, Esteso P, Gambetta K, Hall EK, Kaufman BD, Kirmani S, Lal AK, Martinez HR, Nandi D, O'Connor MJ, Parent JJ, Raucci FJ, Shih R, Shugh S, Soslow JH, Tunuguntla H, Wittlieb-Weber CA, Kinnett K, Cripe L. Current Practices in Treating Cardiomyopathy and Heart Failure in Duchenne Muscular Dystrophy (DMD): Understanding Care Practices in Order to Optimize DMD Heart Failure Through ACTION. Pediatr Cardiol. 2022 Jun; 43(5):977-985.
-
Desai VG, Vijay V, Han T, Moland CL, Phanavanh B, Lee T, Davis KJ, Muskhelishvili L, Stine KC, Fuscoe JC. Doxorubicin-induced delayed-onset subclinical cardiotoxicity in mice. J Appl Toxicol. 2022 05; 42(5):778-792.
-
Butto A, Mao CY, Wright L, Wetzel M, Kelleman MS, Carboni MP, Dipchand AI, Knecht KR, Reinhardt Z, Sparks JD, Villa C, Mahle WT. Relationship of ventricular assist device support duration with pediatric heart transplant outcomes. J Heart Lung Transplant. 2022 01; 41(1):61-69.
-
Henson SE, Lang SM, Khoury PR, Tian C, Rutter MM, Urbina EM, Ryan TD, Taylor MD, Alsaied T. The Effect of Adiposity on Cardiovascular Function and Myocardial Fibrosis in Patients With Duchenne Muscular Dystrophy. J Am Heart Assoc. 2021 10 05; 10(19):e021037.
-
Nadeem U, Raafey M, Kim G, Treger J, Pytel P, N Husain A, Schulte JJ. Chloroquine- and Hydroxychloroquine-Induced Cardiomyopathy: A Case Report and Brief Literature Review. Am J Clin Pathol. 2021 05 18; 155(6):793-801.
-
Bagchi AK, Malik A, Akolkar G, Zimmer A, Bell?-Klein A, De Angelis K, Jassal DS, Fini MA, Stenmark KR, Singal PK. Study of ER stress and apoptotic proteins in the heart and tumor exposed to doxorubicin. Biochim Biophys Acta Mol Cell Res. 2021 06; 1868(7):119039.
-
Nishimura T, Patel HN, Wang S, Upadhyay GA, Smith HL, Ozcan C, Shatz DY, Nayak HM, Patel AR, Tung R. Prognostic value of cardiac magnetic resonance septal late gadolinium enhancement patterns for periaortic ventricular tachycardia ablation: Heterogeneity of the anteroseptal substrate in nonischemic cardiomyopathy. Heart Rhythm. 2021 04; 18(4):579-588.
-
Siddiqui S, Alsaied T, Henson SE, Gandhi J, Patel P, Khoury P, Villa C, Ryan TD, Wittekind SG, Lang SM, Taylor MD. Left Ventricular Magnetic Resonance Imaging Strain Predicts the Onset of Duchenne Muscular Dystrophy-Associated Cardiomyopathy. Circ Cardiovasc Imaging. 2020 11; 13(11):e011526.
-
Lang SM, Alsaied T, Khoury PR, Ryan TD, Taylor MD. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement. Int J Cardiovasc Imaging. 2021 Feb; 37(2):635-642.
-
Singh R, Devabhaktuni S, Ezzeddine F, Simon J, Khaira K, Dandamudi G. His-bundle pacing: A novel treatment for left bundle branch block-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2020 10; 31(10):2730-2736.
-
Park J, Yang K, Lee SH, Lee JH, Min JJ, Kwon JH, Oh AR, Yeo J, Kim J, Choi JH, Lee SC, Gwon HC, Kim K, Ahn J, Lee SM. Comparison of acute and chronic myocardial injury in noncardiac surgical patients. PLoS One. 2020; 15(7):e0234776.
-
Ostwani W, Hanna C, Brice AE, Wymer DC. Waxing and Waning Presentation of Isolated Cardiac Sarcoidosis on Sequential 18F-FDG PET Examinations. J Nucl Med Technol. 2020 Dec; 48(4):378-380.
-
Wittlieb-Weber CA, Knecht KR, Villa CR, Cunningham C, Conway J, Bock MJ, Gambetta KE, Lal AK, Schumacher KR, Law SP, Deshpande SR, West SC, Friedland-Little JM, Lytrivi ID, McCulloch MA, Butts RJ, Weber DR, Johnson JN. Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy. Pediatr Cardiol. 2020 Apr; 41(4):764-771.
-
Gupta K, Jadhav R, Prasad R, Virmani S. Cardiac uptake patterns in routine 18F-FDG PET-CT scans: A pictorial review. J Nucl Cardiol. 2020 08; 27(4):1296-1305.
-
Dasgupta S, Madani R, Figueroa J, Cox D, Ferguson E, Border W, Sachdeva R, Fischbach P, Whitehill R. Myocardial deformation as a predictor of right ventricular pacing-induced cardiomyopathy in the pediatric population. J Cardiovasc Electrophysiol. 2020 01; 31(1):337-344.
-
Lang SM, Alsaied T, Moore RA, Rattan M, Ryan TD, Taylor MD. Conservative gadolinium administration to patients with Duchenne muscular dystrophy: decreasing exposure, cost, and time, without change in medical management. Int J Cardiovasc Imaging. 2019 Dec; 35(12):2213-2219.
-
Bradford TT, Daily JA, Lang SM, Gossett JM, Tang X, Collins RT. Comparison of inhospital outcomes of pediatric heart transplantation between single ventricle congenital heart disease and cardiomyopathy. Pediatr Transplant. 2019 09; 23(6):e13495.
-
Abdul Ghaffar Y, Maskoun W, Mustafa NG, Feigenbaum H, Sawada SG. Low dose wall motion score predicts the short and long-term benefit of surgical revascularization in patients with ischemic left ventricular dysfunction. Int J Cardiovasc Imaging. 2019 Sep; 35(9):1651-1659.
-
Ritter A, Cuddapah S, Degenhardt K, Kasperski S, Johnson MP, O'Connor MJ, Ahrens-Nicklas R. Fetal cardiomyopathy in neurofibromatosis type I: Novel phenotype and review of the literature. Am J Med Genet A. 2019 06; 179(6):1042-1046.
-
Nawaytou HM, Montero AE, Yubbu P, Calder?n-Anyosa RJC, Sato T, O'Connor MJ, Miller KD, Ursell PC, Hoffman JIE, Banerjee A. A Preliminary Study of Left Ventricular Rotational Mechanics in Children with Noncompaction Cardiomyopathy: Do They Influence Ventricular Function? J Am Soc Echocardiogr. 2018 08; 31(8):951-961.
-
Maskoun W, Saad M, Abualsuod A, Nairooz R, Miller JM. Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials. Int J Cardiol. 2018 Sep 15; 267:107-113.
-
Armstrong BA, Betzold RD, May AK. Sepsis and Septic Shock Strategies. Surg Clin North Am. 2017 Dec; 97(6):1339-1379.
-
Akolkar G, da Silva Dias D, Ayyappan P, Bagchi AK, Jassal DS, Salemi VMC, Irigoyen MC, De Angelis K, Singal PK. Vitamin C mitigates oxidative/nitrosative stress and inflammation in doxorubicin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol. 2017 Oct 01; 313(4):H795-H809.
-
Wen JJ, Porter C, Garg NJ. Inhibition of NFE2L2-Antioxidant Response Element Pathway by Mitochondrial Reactive Oxygen Species Contributes to Development of Cardiomyopathy and Left Ventricular Dysfunction in Chagas Disease. Antioxid Redox Signal. 2017 Sep 20; 27(9):550-566.
-
Schloemer NJ, Brickler M, Hoffmann R, Pan A, Simpson P, McFadden V, Block J, Tower RL, Burke MJ. Administration of Dexrazoxane Improves Cardiac Indices in Children and Young Adults With Acute Myeloid Leukemia (AML) While Maintaining Survival Outcomes. J Pediatr Hematol Oncol. 2017 07; 39(5):e254-e258.
-
Atreya AR, Patel M, Sivalingam SK, Stoenescu ML. Isolated cardiac sarcoidosis masquerading as right ventricular outflow tract ventricular tachycardia. BMJ Case Rep. 2017 Jun 30; 2017.
-
Barakat AF, Saad M, Elgendy IY. Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis". Circulation. 2017 06 20; 135(25):e1196-e1197.
-
Bhatti S, Vallurupalli S, Ambach S, Magier A, Watts E, Truong V, Hakeem A, Mazur W. Myocardial strain pattern in patients with cardiac amyloidosis secondary to multiple myeloma: a cardiac MRI feature tracking study. Int J Cardiovasc Imaging. 2018 Jan; 34(1):27-33.
-
Raina S, Lensing SY, Nairooz RS, Pothineni NV, Hakeem A, Bhatti S, Pandey T. Prognostic Value of Late?Gadolinium?Enhancement CMR in?Systemic Amyloidosis. JACC Cardiovasc Imaging. 2016 11; 9(11):1267-1277.
-
Abraham BP, Gilliam E, Kim DW, Wolf MJ, Vincent RN, Petit CJ. Early catheterization after initiation of extracorporeal membrane oxygenation support in children is associated with improved survival. Catheter Cardiovasc Interv. 2016 Oct; 88(4):592-599.
-
Niss O, Quinn CT, Lane A, Daily J, Khoury PR, Bakeer N, Kimball TR, Towbin JA, Malik P, Taylor MD. Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease. JACC Cardiovasc Imaging. 2016 Mar; 9(3):243-52.
-
Morris L, Desai A, Akkus NI. Anterolateral papillary muscle rupture after intervention of the right coronary artery. Rev Port Cardiol. 2015 Nov; 34(11):693.e1-3.
-
Birnkrant DJ, Ararat E, Mhanna MJ. Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol. 2016 Jan; 51(1):70-6.
-
Vallurupalli S, Pothineni NV, Deshmukh A, Paydak H. Utility of Routine Exercise Testing to Detect Rate-Related QRS Widening in Patients Without Structural Heart Disease on Class Ic Antiarrhythmic Agents (Flecainide and?Propafenone). Am J Cardiol. 2015 Sep 01; 116(5):730-2.
-
Rossano JW, O'Connor MJ. Sudden cardiac death in pediatric cardiomyopathy: the importance of well-designed population-based studies. J Am Coll Cardiol. 2015 Jun 02; 65(21):2311-3.
-
Singh P, Sharma R, McElhanon K, Allen CD, Megyesi JK, Bene? H, Singh SP. Sulforaphane protects the heart from doxorubicin-induced toxicity. Free Radic Biol Med. 2015 Sep; 86:90-101.
-
Lang SM, Shugh S, Mazur W, Sticka JJ, Rattan MS, Jefferies JL, Taylor MD. Myocardial Fibrosis and Left Ventricular Dysfunction in Duchenne Muscular Dystrophy Carriers Using Cardiac Magnetic Resonance Imaging. Pediatr Cardiol. 2015 Oct; 36(7):1495-501.
-
Cai R, Gu J, Sun H, Liu X, Mei W, Qi Y, Xue S, Ren S, Rabinowitz JE, Wang Y, Yeh ET, Cheng J. Induction of SENP1 in myocardium contributes to abnormities of mitochondria and cardiomyopathy. J Mol Cell Cardiol. 2015 Feb; 79:115-22.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|